Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid Tumors.
Journal: Cancer research communications
Published: June 02, 2025
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells.
Journal: Science advances
Published: January 10, 2025
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors.
Journal: Pediatric blood & cancer
Published: November 21, 2024
Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas.
Journal: Cancer immunology research
Published: September 13, 2024
A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function.
Journal: Cancer research communications
Published: February 28, 2024
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.
Journal: Cytotherapy
Published: August 13, 2023
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.
Journal: Nature cancer
Published: December 23, 2022
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.
Journal: Blood advances
Published: September 27, 2022
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
Journal: The Journal of clinical investigation
Published: July 01, 2021
Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.
Journal: Nature medicine
Published: May 28, 2021
Immunogenicity of CAR T cells in cancer therapy.
Journal: Nature reviews. Clinical oncology
Published: January 14, 2021
Last Updated: 09/26/2026